Treatment of Neovascular Age-related Macular Degeneration with Intravitreal Bevacizumab: Efficacy of Three Consecutive Monthly Injections

Ranibizumab for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text

Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

David M. Brown, Peter K. Kaiser, Mark Michels et al. · New England Journal of Medicine · 2006 · 3.5K citations

Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration

Robert L. Avery, Dante J. Pieramici, Melvin Rabena et al. · Ophthalmology · 2006 · 1.1K citations

Ocular Disease, Vitreous Body, Ophthalmology +2

Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study

S. Michels, Philip J. Rosenfeld, C PULIAFITO et al. · Ophthalmology · 2005 · 667 citations · Full text

Ocular Disease, Ophthalmology, Experimental Ophthalmology +4

Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor

Anders Kvanta, PV Algvere, Lena Berglin et al. · American Journal of Ophthalmology · 1996 · 621 citations

Ocular Disease, Angiogenesis, Aging +12